These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1105 related articles for article (PubMed ID: 23993863)

  • 1. Mesenchymal differentiation mediated by NF-κB promotes radiation resistance in glioblastoma.
    Bhat KPL; Balasubramaniyan V; Vaillant B; Ezhilarasan R; Hummelink K; Hollingsworth F; Wani K; Heathcock L; James JD; Goodman LD; Conroy S; Long L; Lelic N; Wang S; Gumin J; Raj D; Kodama Y; Raghunathan A; Olar A; Joshi K; Pelloski CE; Heimberger A; Kim SH; Cahill DP; Rao G; Den Dunnen WFA; Boddeke HWGM; Phillips HS; Nakano I; Lang FF; Colman H; Sulman EP; Aldape K
    Cancer Cell; 2013 Sep; 24(3):331-46. PubMed ID: 23993863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. lncRNA LINC01057 promotes mesenchymal differentiation by activating NF-κB signaling in glioblastoma.
    Tang G; Luo L; Zhang J; Zhai D; Huang D; Yin J; Zhou Q; Zhang Q; Zheng G
    Cancer Lett; 2021 Feb; 498():152-164. PubMed ID: 33130316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peroxisome proliferator-activated receptor gamma as a theragnostic target for mesenchymal-type glioblastoma patients.
    Hua TNM; Oh J; Kim S; Antonio JM; Vo VTA; Om J; Choi JW; Kim JY; Jung CW; Park MJ; Jeong Y
    Exp Mol Med; 2020 Apr; 52(4):629-642. PubMed ID: 32280134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear factor I A promotes temozolomide resistance in glioblastoma via activation of nuclear factor κB pathway.
    Yu X; Wang M; Zuo J; Wahafu A; Mao P; Li R; Wu W; Xie W; Wang J
    Life Sci; 2019 Nov; 236():116917. PubMed ID: 31614149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of CD133 and CD44 in glioblastoma stem cells correlates with cell proliferation, phenotype stability and intra-tumor heterogeneity.
    Brown DV; Filiz G; Daniel PM; Hollande F; Dworkin S; Amiridis S; Kountouri N; Ng W; Morokoff AP; Mantamadiotis T
    PLoS One; 2017; 12(2):e0172791. PubMed ID: 28241049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The NF-κB RelB protein is an oncogenic driver of mesenchymal glioma.
    Lee DW; Ramakrishnan D; Valenta J; Parney IF; Bayless KJ; Sitcheran R
    PLoS One; 2013; 8(2):e57489. PubMed ID: 23451236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-181d/MALT1 regulatory axis attenuates mesenchymal phenotype through NF-κB pathways in glioblastoma.
    Yang F; Liu X; Liu Y; Liu Y; Zhang C; Wang Z; Jiang T; Wang Y
    Cancer Lett; 2017 Jun; 396():1-9. PubMed ID: 28286260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A DNA methylation prognostic signature of glioblastoma: identification of NPTX2-PTEN-NF-κB nexus.
    Shukla S; Pia Patric IR; Thinagararjan S; Srinivasan S; Mondal B; Hegde AS; Chandramouli BA; Santosh V; Arivazhagan A; Somasundaram K
    Cancer Res; 2013 Nov; 73(22):6563-73. PubMed ID: 24078801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silencing LncRNA LOXL1-AS1 attenuates mesenchymal characteristics of glioblastoma via NF-κB pathway.
    Wang H; Li L; Yin L
    Biochem Biophys Res Commun; 2018 Jun; 500(2):518-524. PubMed ID: 29678575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The proneural gene ASCL1 governs the transcriptional subgroup affiliation in glioblastoma stem cells by directly repressing the mesenchymal gene NDRG1.
    Narayanan A; Gagliardi F; Gallotti AL; Mazzoleni S; Cominelli M; Fagnocchi L; Pala M; Piras IS; Zordan P; Moretta N; Tratta E; Brugnara G; Altabella L; Bozzuto G; Gorombei P; Molinari A; Padua RA; Bulfone A; Politi LS; Falini A; Castellano A; Mortini P; Zippo A; Poliani PL; Galli R
    Cell Death Differ; 2019 Sep; 26(9):1813-1831. PubMed ID: 30538287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SPI1-mediated MIR222HG transcription promotes proneural-to-mesenchymal transition of glioma stem cells and immunosuppressive polarization of macrophages.
    Fan Y; Gao Z; Xu J; Wang H; Guo Q; Li B; Li M; Xu H; Qi Y; Zhao S; Qiu W; Pan Z; Wang Q; Xue H; Zhao R; Guo X; Li G
    Theranostics; 2023; 13(10):3310-3329. PubMed ID: 37351164
    [No Abstract]   [Full Text] [Related]  

  • 12. FOSL1 promotes proneural-to-mesenchymal transition of glioblastoma stem cells via UBC9/CYLD/NF-κB axis.
    Chen Z; Wang S; Li HL; Luo H; Wu X; Lu J; Wang HW; Chen Y; Chen D; Wu WT; Zhang S; He Q; Lu D; Liu N; You Y; Wu W; Wang H
    Mol Ther; 2022 Jul; 30(7):2568-2583. PubMed ID: 35351656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Constitutive activation of signal transducer and activator of transcription 3 (STAT3) and nuclear factor κB signaling in glioblastoma cancer stem cells regulates the Notch pathway.
    Garner JM; Fan M; Yang CH; Du Z; Sims M; Davidoff AM; Pfeffer LM
    J Biol Chem; 2013 Sep; 288(36):26167-26176. PubMed ID: 23902772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spliceosome-regulated RSRP1-dependent NF-κB activation promotes the glioblastoma mesenchymal phenotype.
    Li Y; Wang X; Qi S; Gao L; Huang G; Ren Z; Li K; Peng Y; Yi G; Guo J; Yang R; Wang H; Zhang X; Liu Y
    Neuro Oncol; 2021 Oct; 23(10):1693-1708. PubMed ID: 34042961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proinvasive extracellular matrix remodeling in tumor microenvironment in response to radiation.
    Yoo KC; Suh Y; An Y; Lee HJ; Jeong YJ; Uddin N; Cui YH; Roh TH; Shim JK; Chang JH; Park JB; Kim MJ; Kim IG; Kang SG; Lee SJ
    Oncogene; 2018 Jun; 37(24):3317-3328. PubMed ID: 29559744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long Noncoding RNA
    Ji J; Xu R; Ding K; Bao G; Zhang X; Huang B; Wang X; Martinez A; Wang X; Li G; Miletic H; Thorsen F; Bjerkvig R; Xiang L; Han B; Chen A; Li X; Wang J
    Clin Cancer Res; 2019 Nov; 25(22):6868-6881. PubMed ID: 31492748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LGR5 is a proneural factor and is regulated by OLIG2 in glioma stem-like cells.
    Mao XG; Song SJ; Xue XY; Yan M; Wang L; Lin W; Guo G; Zhang X
    Cell Mol Neurobiol; 2013 Aug; 33(6):851-65. PubMed ID: 23793848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal glioma stem cells are maintained by activated glycolytic metabolism involving aldehyde dehydrogenase 1A3.
    Mao P; Joshi K; Li J; Kim SH; Li P; Santana-Santos L; Luthra S; Chandran UR; Benos PV; Smith L; Wang M; Hu B; Cheng SY; Sobol RW; Nakano I
    Proc Natl Acad Sci U S A; 2013 May; 110(21):8644-9. PubMed ID: 23650391
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serine/Threonine Kinase MLK4 Determines Mesenchymal Identity in Glioma Stem Cells in an NF-κB-dependent Manner.
    Kim SH; Ezhilarasan R; Phillips E; Gallego-Perez D; Sparks A; Taylor D; Ladner K; Furuta T; Sabit H; Chhipa R; Cho JH; Mohyeldin A; Beck S; Kurozumi K; Kuroiwa T; Iwata R; Asai A; Kim J; Sulman EP; Cheng SY; Lee LJ; Nakada M; Guttridge D; DasGupta B; Goidts V; Bhat KP; Nakano I
    Cancer Cell; 2016 Feb; 29(2):201-13. PubMed ID: 26859459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BIRC3 is a biomarker of mesenchymal habitat of glioblastoma, and a mediator of survival adaptation in hypoxia-driven glioblastoma habitats.
    Wang D; Berglund AE; Kenchappa RS; MacAulay RJ; Mulé JJ; Etame AB
    Sci Rep; 2017 Aug; 7(1):9350. PubMed ID: 28839258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.